• Alkermes/Biogen hope for less tummy trouble with new MS pill pharmaphorum
    December 19, 2018
    Alkermes and Biogen have filed a new multiple sclerosis pill with the FDA, which they hope will treat the disease with fewer unpleasant gastrointestinal side effects than the big pharma’s older MS drug, Tecfidera.
PharmaSources Customer Service